118 related articles for article (PubMed ID: 9554589)
1. Expression of Bcl-2 in human epithelial tumor (HeLa) cells enhances clonogenic survival following exposure to 5-fluoro-2'-deoxyuridine or staurosporine, but not following exposure to etoposide or doxorubicin.
Elliott MJ; Stribinskiene L; Lock RB
Cancer Chemother Pharmacol; 1998; 41(6):457-63. PubMed ID: 9554589
[TBL] [Abstract][Full Text] [Related]
2. Bcl-2 inhibits early apoptotic events and reveals post-mitotic multinucleation without affecting cell cycle arrest in human epithelial tumor cells exposed to etoposide.
Elliott MJ; Murphy KM; Stribinskiene L; Ranganathan V; Sturges E; Farnsworth ML; Lock RB
Cancer Chemother Pharmacol; 1999; 44(1):1-11. PubMed ID: 10367743
[TBL] [Abstract][Full Text] [Related]
3. Dual modes of death induced by etoposide in human epithelial tumor cells allow Bcl-2 to inhibit apoptosis without affecting clonogenic survival.
Lock RB; Stribinskiene L
Cancer Res; 1996 Sep; 56(17):4006-12. PubMed ID: 8752171
[TBL] [Abstract][Full Text] [Related]
4. Potentiation of etoposide-induced apoptosis by staurosporine in human tumor cells is associated with events downstream of DNA-protein complex formation.
Lock RB; Thompson BS; Sullivan DM; Stribinskiene L
Cancer Chemother Pharmacol; 1997; 39(5):399-409. PubMed ID: 9054953
[TBL] [Abstract][Full Text] [Related]
5. Modulation of apoptosis and enhancement of chemosensitivity by decreasing cellular thiols in a mouse B-cell lymphoma cell line that overexpresses bcl-2.
Story MD; Meyn RE
Cancer Chemother Pharmacol; 1999; 44(5):362-6. PubMed ID: 10501908
[TBL] [Abstract][Full Text] [Related]
6. Human melanoma cell lines selected in vitro displaying various levels of drug resistance against cisplatin, fotemustine, vindesine or etoposide: modulation of proto-oncogene expression.
Kern MA; Helmbach H; Artuc M; Karmann D; Jurgovsky K; Schadendorf D
Anticancer Res; 1997; 17(6D):4359-70. PubMed ID: 9494534
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapeutic agents enhance TRAIL-induced apoptosis in prostate cancer cells.
Munshi A; McDonnell TJ; Meyn RE
Cancer Chemother Pharmacol; 2002 Jul; 50(1):46-52. PubMed ID: 12111111
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2- or Bcl-xL-overexpressing chemotherapy-resistant tumor cells.
Walczak H; Bouchon A; Stahl H; Krammer PH
Cancer Res; 2000 Jun; 60(11):3051-7. PubMed ID: 10850456
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor inhibits apoptotic death in hematopoietic cells after exposure to chemotherapeutic drugs by inducing MCL1 acting as an antiapoptotic factor.
Katoh O; Takahashi T; Oguri T; Kuramoto K; Mihara K; Kobayashi M; Hirata S; Watanabe H
Cancer Res; 1998 Dec; 58(23):5565-9. PubMed ID: 9850095
[TBL] [Abstract][Full Text] [Related]
10. Endogenously produced ganglioside GM3 endows etoposide and doxorubicin resistance by up-regulating Bcl-2 expression in 3LL Lewis lung carcinoma cells.
Noguchi M; Kabayama K; Uemura S; Kang BW; Saito M; Igarashi Y; Inokuchi J
Glycobiology; 2006 Jul; 16(7):641-50. PubMed ID: 16571667
[TBL] [Abstract][Full Text] [Related]
11. Anticancer drugs induce necrosis of human endothelial cells involving both oncosis and apoptosis.
Mailloux A; Grenet K; Bruneel A; Bénéteau-Burnat B; Vaubourdolle M; Baudin B
Eur J Cell Biol; 2001 Jun; 80(6):442-9. PubMed ID: 11484935
[TBL] [Abstract][Full Text] [Related]
12. Evidence against a direct role for the induction of c-jun expression in the mediation of drug-induced apoptosis in human acute leukemia cells.
Bullock G; Ray S; Reed J; Miyashita T; Maria Ibrado A; Huang Y; Bhalla K
Clin Cancer Res; 1995 May; 1(5):559-64. PubMed ID: 9816016
[TBL] [Abstract][Full Text] [Related]
13. Bcl-2 inhibits Bax translocation from cytosol to mitochondria during drug-induced apoptosis of human tumor cells.
Murphy KM; Ranganathan V; Farnsworth ML; Kavallaris M; Lock RB
Cell Death Differ; 2000 Jan; 7(1):102-11. PubMed ID: 10713725
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Bcl-2 and Bcl-X enhances chemotherapy sensitivity in hepatoblastoma cells.
Lieber J; Kirchner B; Eicher C; Warmann SW; Seitz G; Fuchs J; Armeanu-Ebinger S
Pediatr Blood Cancer; 2010 Dec; 55(6):1089-95. PubMed ID: 20680965
[TBL] [Abstract][Full Text] [Related]
15. Inducible overexpression of Bak sensitizes HCC-9204 cells to apoptosis induced by doxorubicin.
Li J; Wang WL; Yang XK; Yu XX; Hou YD; Zhang J
Acta Pharmacol Sin; 2000 Sep; 21(9):769-76. PubMed ID: 11501155
[TBL] [Abstract][Full Text] [Related]
16. Scatter factor protects epithelial and carcinoma cells against apoptosis induced by DNA-damaging agents.
Fan S; Wang JA; Yuan RQ; Rockwell S; Andres J; Zlatapolskiy A; Goldberg ID; Rosen EM
Oncogene; 1998 Jul; 17(2):131-41. PubMed ID: 9674697
[TBL] [Abstract][Full Text] [Related]
17. Interferon-gamma induces apoptosis and expression of inflammation-related proteins in Chang conjunctival cells.
De Saint Jean M; Brignole F; Feldmann G; Goguel A; Baudouin C
Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2199-212. PubMed ID: 10476784
[TBL] [Abstract][Full Text] [Related]
18. Exposure to low concentrations of etoposide reduces the apoptotic capability of leukaemic cell lines.
Liu WM; Oakley PR; Joel SP
Leukemia; 2002 Sep; 16(9):1705-12. PubMed ID: 12200685
[TBL] [Abstract][Full Text] [Related]
19. Lovastatin protects human endothelial cells from the genotoxic and cytotoxic effects of the anticancer drugs doxorubicin and etoposide.
Damrot J; Nübel T; Epe B; Roos WP; Kaina B; Fritz G
Br J Pharmacol; 2006 Dec; 149(8):988-97. PubMed ID: 17088865
[TBL] [Abstract][Full Text] [Related]
20. The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis.
Tolomeo M; Dusonchet L; Meli M; Grimaudo S; D'Alessandro N; Papoff G; Ruberti G; Rausa L
Cell Death Differ; 1998 Sep; 5(9):735-42. PubMed ID: 10200532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
